Literature DB >> 19123469

The clonal evolution of metastases from primary serous epithelial ovarian cancers.

Lalarukh Khalique1, Ayse Ayhan, John C Whittaker, Naveena Singh, Ian J Jacobs, Simon A Gayther, Susan J Ramus.   

Abstract

Several models of evolution from primary cancers to metastases have been proposed; but the most widely accepted is the clonal evolution model proposed for colorectal cancer in which tumors develop by a process of linear clonal evolution driven by the accumulation of somatic genetic alterations. Various other models of cancer progression and metastasis have been proposed, including parallel evolution and the same gene model. The aim of this study was to investigate the evolution of metastases from primary cancer in 22 patients diagnosed with high-grade serous epithelial ovarian cancer. We established somatic genetic profiles based on the pattern of loss of heterozygosity, in several different regions of tumor tissue within the primary tumor and metastatic deposits from each case. Maximum parsimony tree analysis was used to examine the evolutionary relationship between the primary and metastatic samples for each patient. In addition, we investigated the extent of genetic heterogeneity within and between metastatic tumors compared with primary ovarian tumors. Our data suggest that most, if not all, metastases are clonally related to the primary tumors. However, the data oppose a single model of linear-clonal evolution whereby a late stage clone within the primary tumor acquires additional genetic changes that enable metastatic progression. Instead, the data support a model in which primary ovarian cancers have a common clonal origin, but become polyclonal, with different clones at both early and late stages of genetic divergence acquiring the ability to progress to metastasis.

Entities:  

Mesh:

Year:  2009        PMID: 19123469     DOI: 10.1002/ijc.24148

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  34 in total

Review 1.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

Review 2.  Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence.

Authors:  Mark E Sherman; Ronny I Drapkin; Neil S Horowitz; Christopher P Crum; Sue Friedman; Janice S Kwon; Douglas A Levine; Ie-Ming Shih; Donna Shoupe; Elizabeth M Swisher; Joan Walker; Britton Trabert; Mark H Greene; Goli Samimi; Sarah M Temkin; Lori M Minasian
Journal:  Cancer Prev Res (Phila)       Date:  2016-05-24

3.  Genetic analysis of uterine aspirates improves the diagnostic value and captures the intra-tumor heterogeneity of endometrial cancers.

Authors:  Alba Mota; Eva Colás; Pablo García-Sanz; Irene Campoy; Alejandro Rojo-Sebastián; Sonia Gatius; Ángel García; Luis Chiva; Sonsoles Alonso; Antonio Gil-Moreno; Xavier González-Tallada; Berta Díaz-Feijoo; August Vidal; Patrycja Ziober-Malinowska; Marcin Bobiński; Rafael López-López; Miguel Abal; Jaume Reventós; Xavier Matias-Guiu; Gema Moreno-Bueno
Journal:  Mod Pathol       Date:  2016-09-02       Impact factor: 7.842

4.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 5.  Mechanisms and Targets Involved in Dissemination of Ovarian Cancer.

Authors:  Ulrich H Weidle; Fabian Birzele; Gwendlyn Kollmorgen; Rüdiger Rueger
Journal:  Cancer Genomics Proteomics       Date:  2016 11-12       Impact factor: 4.069

6.  Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.

Authors:  Andrea R Hagemann; Ian S Hagemann; Mark Cadungog; Wei-Ting Hwang; Priya Patel; Priti Lal; Rachel Hammond; Phyllis A Gimotty; Christina S Chu; Steven C Rubin; Michael J Birrer; Daniel J Powell; Michael D Feldman; George Coukos
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

7.  Radiogenomics of High-Grade Serous Ovarian Cancer: Multireader Multi-Institutional Study from the Cancer Genome Atlas Ovarian Cancer Imaging Research Group.

Authors:  Hebert Alberto Vargas; Erich P Huang; Yulia Lakhman; Joseph E Ippolito; Priya Bhosale; Vincent Mellnick; Atul B Shinagare; Maria Anello; Justin Kirby; Brenda Fevrier-Sullivan; John Freymann; C Carl Jaffe; Evis Sala
Journal:  Radiology       Date:  2017-06-22       Impact factor: 11.105

8.  The detection, treatment, and biology of epithelial ovarian cancer.

Authors:  Jennifer Aa Gubbels; Nick Claussen; Arvinder K Kapur; Joseph P Connor; Manish S Patankar
Journal:  J Ovarian Res       Date:  2010-03-29       Impact factor: 4.234

9.  Divergent modes of clonal spread and intraperitoneal mixing in high-grade serous ovarian cancer.

Authors:  Andrew McPherson; Andrew Roth; Emma Laks; Tehmina Masud; Ali Bashashati; Allen W Zhang; Gavin Ha; Justina Biele; Damian Yap; Adrian Wan; Leah M Prentice; Jaswinder Khattra; Maia A Smith; Cydney B Nielsen; Sarah C Mullaly; Steve Kalloger; Anthony Karnezis; Karey Shumansky; Celia Siu; Jamie Rosner; Hector Li Chan; Julie Ho; Nataliya Melnyk; Janine Senz; Winnie Yang; Richard Moore; Andrew J Mungall; Marco A Marra; Alexandre Bouchard-Côté; C Blake Gilks; David G Huntsman; Jessica N McAlpine; Samuel Aparicio; Sohrab P Shah
Journal:  Nat Genet       Date:  2016-05-16       Impact factor: 38.330

10.  Gene expression data reveal common pathways that characterize the unifocal nature of ovarian cancer.

Authors:  Douglas C Marchion; Yin Xiong; Hye Sook Chon; Entidhar Al Sawah; Nadim Bou Zgheib; Ingrid J Ramirez; Forough Abbasi; Xiaomang B Stickles; Patricia L Judson; Ardeshir Hakam; Jesus Gonzalez-Bosquet; Robert M Wenham; Sachin M Apte; Anders E Berglund; Johnathan M Lancaster
Journal:  Am J Obstet Gynecol       Date:  2013-08-09       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.